{"id":"W4398244400","doi":"10.1002/ueg2.12584","title":"Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure","year":2024,"lang":"en","type":"article","venue":"United European Gastroenterology Journal","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Ulcerative colitis; Janus kinase inhibitor; Adverse effect; Internal medicine; Gastroenterology; Placebo; Surgery; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009164904,0.0001467117,0.0002425545,0.0001997328,0.00004505956,0.00003056611,0.0003652081,0.00005253415,0.00008951092],"category_scores_gemma":[0.0001520534,0.000126325,0.0002524827,0.0003697422,0.0002326757,0.000006004289,0.0001914889,0.0002697274,0.000007925621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003875735,"about_ca_system_score_gemma":0.0000973168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001722087,"about_ca_topic_score_gemma":0.0006858552,"domain_scores_codex":[0.996859,0.001622506,0.0008227032,0.000273197,0.0001549074,0.0002676639],"domain_scores_gemma":[0.9992712,0.00004942291,0.0001777344,0.0002012864,0.0001498355,0.0001505507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00294724,0.0001096961,0.98719,0.000005296839,0.001654182,0.000410442,0.0005990827,0.0005898132,0.0004511783,0.00002008452,0.001344948,0.004678023],"study_design_scores_gemma":[0.001155427,0.0003685036,0.9942245,0.00004853254,0.0002357065,0.00004856181,0.0005257702,0.0002881479,0.00002237297,0.00000447737,0.003007831,0.00007012414],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976856,0.00003308796,0.0006177413,0.0001336566,0.0002236313,0.0002001279,0.0009274698,0.00001117111,0.0001675141],"genre_scores_gemma":[0.9980385,0.00003367885,0.0006002969,0.0006105776,0.0001084886,0.00000338508,0.0005662092,0.00001605486,0.00002276382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007034533,"threshold_uncertainty_score":0.5151384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01512914052545138,"score_gpt":0.2875723272249918,"score_spread":0.2724431866995404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}